ETFIQData as of Nov 19, 2026. · etfiq.com/funds/vhtDownload PDF

VHT Fact Sheet: Vanguard Health Care ETF

Share
$326.69
close, Nov 20, 2026

Over the year to Nov 19, 2026, VHT returned +17.5% in total and charged 0.09% a year.

1-year total return
+17.8%
FHLC +17.9% to Nov 20, 2026
Expense ratio
0.09%
a year
Net assets
$20.8bn
on Oct 31, 2026

Growth of $10,000, 1 year

VHT $11,753 +17.5% · FHLC $11,765 +17.6% · Total return, distributions reinvested, Nov 19, 2025 to Nov 19, 2026.

Returns

WindowTotal return
1 month−1.7%
3 months0.0%
Year to date+14.7%
1 year+17.8%
3 years+45.0%
5 years+37.4%

Total return, distributions reinvested, each window to Nov 20, 2026.

Ten largest positions

HoldingWeight
Eli Lilly & Co14.69%
Johnson & Johnson8.40%
AbbVie Inc6.74%
UnitedHealth Group Inc4.78%
Merck & Co Inc4.78%
Thermo Fisher Scientific Inc3.35%
Amgen Inc3.25%
Gilead Sciences Inc2.74%
Abbott Laboratories2.39%
Pfizer Inc2.25%

VHT top ten by weight, 53.4% of the fund, of its 410 equity positions, from the holdings filed for Oct 31, 2026.

Facts

Equity fund · Tracks the MSCI US Investable Market Index (IMI)/Health Care 25/50 · First traded Jan 30, 2004 · Benchmark MSCI US Investable Market Index (IMI)/Health Care 25/50, measured by FHLC, which tracks the same index

Source: ETFIQ, from issuer disclosures, SEC filings and exchange prices. Returns from daily closes, distributions reinvested; each number is dated beside it, and every one is on the fund’s page.Cite as: ETFIQ, VHT Fact Sheet: Vanguard Health Care ETF. Data as of Nov 19, 2026. https://etfiq.com/funds/vht/fact-sheet/ETFIQ is an independent publisher. Not an issuer, broker or adviser. No recommendations. Printed from etfiq.com/funds/vht.